Bioinformatics Tool for Tracking Tumor-Immune Interactions Could Be Useful for Guiding Therapy
A map for discovering immune checkpoints and tumor process interactions is showing potential in identifying new drug targets and personalizing immunotherapy.
Real-World Study Examines Genomic Profiling Challenges for Patients With Cancers of Unknown Primary
The researchers found that more than half of patients with CUP did not have sufficient tissue to undergo genomic profiling.
WashU Researchers Studying Amyloid-Lowering Insomnia Drug's Effect on Alzheimer's Development
Investigators will assess whether a drug already approved for insomnia decreases the rate of amyloid accumulation in patients at risk for developing Alzheimer's.
EMA's CHMP Recommends BMS's Opdivo, Chemo for Neoadjuvant PD-L1-Positive NSCLC
If approved, the drug combination will be the first immunotherapy-based treatment available in the neoadjuvant setting for NSCLC patients in Europe.
New Bladder Cancer Molecular Classification Predicts Response to Common Immunotherapy
The new subtypes could help clinicians pick alternative therapies for patients unlikely to respond to Bacillus Calmette-Guérin treatment.